Stress- and oligomycin-induced changes of gene expression in MOLT-3 cells
Probe set ID . | Control cells . | Oligomycin . | Doxorubicin . | Doxorubicin + oligomycin . | Etoposide . | Etoposide + oligomycin . | Gene . | Function/pathway . |
---|---|---|---|---|---|---|---|---|
202284_s_at | 14 | 8 | 196 | 18 | 203 | 47 | p21 | Inhibitor of cyclin-dependent kinase activity, p53-target35 |
203725_at | 30 | 41 | 202 | 185 | 324 | 249 | GADD45A | GADD family members; stress and DNA damage response, p53 targets37 |
218346_s_at | 112 | 73 | 384 | 175 | 412 | 247 | PA26 | GADD family members; stress and DNA damage response, p53 targets37 |
205780_at | 110 | 136 | 435 | 159 | 479 | 160 | BIK | Proapoptotic BH-3 only protein; p53 target39 |
208478_s_at | 54 | 68 | 91 | 55 | 117 | 55 | BAX | Proapoptotic p53 target39 |
207813_s_at | 60 | 58 | 326 | 153 | 321 | 132 | FDXR | Ferredoxin reductase, electron transport chain, p53 target36 |
203409_at | 168 | 273 | 593 | 310 | 816 | 532 | DDB2 | DNA damage-binding protein; DNA repair, p53 target37 |
201739_at | 20 | 83 | 117 | 237 | 50 | 447 | SGK | Kinase activity; glucose metabolism, transcriptionally repressed by p5340 |
201694_s_at | 90 | 404 | 58 | 207 | 86 | 314 | EGR1 | Transcription factor; early stress response, transcriptionally repressed by p5341 |
201631_s_at | 105 | 62 | 1543 | 602 | 783 | 552 | IER3/PRG1 | Early stress response; p53 and NF B/rel target73 |
201502_s_at | 479 | 453 | 1974 | 2064 | 718 | 1666 | IKBA | NFκB inhibitor, NFκB target42 |
202871_at | 82 | 102 | 263 | 260 | 258 | 338 | TRAF4 | TNF receptor-associated factor; NF-κB survival signaling43 |
209795_at | 87 | 305 | 311 | 489 | 144 | 618 | CD69 | Signal transmitting receptor, NFκB-target42 |
202672_s_at | 97 | 825 | 642 | 1113 | 601 | 1504 | ATF3 | Transcription factor; stress response46 |
218145_at | 74 | 327 | 70 | 296 | 77 | 349 | TRB3 | Regulator of glucose homeostasis44 |
209822_s_at | 36 | 232 | 34 | 243 | 39 | 238 | VLDLR | Lipoprotein receptor, fatty acid metabolism44 |
212501_at | 225 | 1713 | 312 | 2171 | 243 | 1629 | CEBPb | Transcription factor, regulator of energy homeostasis45 |
202581_s_at | 202 | 63 | 233 | 90 | 118 | 55 | HSP70B | Heat-shock protein |
203478_at | 1403 | 745 | 1294 | 667 | 1312 | 692 | NDUFC1 | NADH dehydrogenase, subunit C1 |
201746_at | 572 | 491 | 443 | 473 | 456 | 519 | p53 | Tumor suppressor; proapoptotic cellular stress response |
Probe set ID . | Control cells . | Oligomycin . | Doxorubicin . | Doxorubicin + oligomycin . | Etoposide . | Etoposide + oligomycin . | Gene . | Function/pathway . |
---|---|---|---|---|---|---|---|---|
202284_s_at | 14 | 8 | 196 | 18 | 203 | 47 | p21 | Inhibitor of cyclin-dependent kinase activity, p53-target35 |
203725_at | 30 | 41 | 202 | 185 | 324 | 249 | GADD45A | GADD family members; stress and DNA damage response, p53 targets37 |
218346_s_at | 112 | 73 | 384 | 175 | 412 | 247 | PA26 | GADD family members; stress and DNA damage response, p53 targets37 |
205780_at | 110 | 136 | 435 | 159 | 479 | 160 | BIK | Proapoptotic BH-3 only protein; p53 target39 |
208478_s_at | 54 | 68 | 91 | 55 | 117 | 55 | BAX | Proapoptotic p53 target39 |
207813_s_at | 60 | 58 | 326 | 153 | 321 | 132 | FDXR | Ferredoxin reductase, electron transport chain, p53 target36 |
203409_at | 168 | 273 | 593 | 310 | 816 | 532 | DDB2 | DNA damage-binding protein; DNA repair, p53 target37 |
201739_at | 20 | 83 | 117 | 237 | 50 | 447 | SGK | Kinase activity; glucose metabolism, transcriptionally repressed by p5340 |
201694_s_at | 90 | 404 | 58 | 207 | 86 | 314 | EGR1 | Transcription factor; early stress response, transcriptionally repressed by p5341 |
201631_s_at | 105 | 62 | 1543 | 602 | 783 | 552 | IER3/PRG1 | Early stress response; p53 and NF B/rel target73 |
201502_s_at | 479 | 453 | 1974 | 2064 | 718 | 1666 | IKBA | NFκB inhibitor, NFκB target42 |
202871_at | 82 | 102 | 263 | 260 | 258 | 338 | TRAF4 | TNF receptor-associated factor; NF-κB survival signaling43 |
209795_at | 87 | 305 | 311 | 489 | 144 | 618 | CD69 | Signal transmitting receptor, NFκB-target42 |
202672_s_at | 97 | 825 | 642 | 1113 | 601 | 1504 | ATF3 | Transcription factor; stress response46 |
218145_at | 74 | 327 | 70 | 296 | 77 | 349 | TRB3 | Regulator of glucose homeostasis44 |
209822_s_at | 36 | 232 | 34 | 243 | 39 | 238 | VLDLR | Lipoprotein receptor, fatty acid metabolism44 |
212501_at | 225 | 1713 | 312 | 2171 | 243 | 1629 | CEBPb | Transcription factor, regulator of energy homeostasis45 |
202581_s_at | 202 | 63 | 233 | 90 | 118 | 55 | HSP70B | Heat-shock protein |
203478_at | 1403 | 745 | 1294 | 667 | 1312 | 692 | NDUFC1 | NADH dehydrogenase, subunit C1 |
201746_at | 572 | 491 | 443 | 473 | 456 | 519 | p53 | Tumor suppressor; proapoptotic cellular stress response |
MOLT-3 cells were treated with etoposide (1 μM) or doxorubicin (1 μM) in the presence or absence of oligomycin (10 μg/mL) for 3 hours and mRNA expression levels (quantified in fluorescence intensity units) were assessed using Affymetrix HG Focus Arrays. Control cells were investigated by 2 independent preparations, and mean gene expression values are given.